Executive record

John Tattory

John Tattory holds the CFO seat at TransCode Therapeutics, Inc. on the record, Interim Chief Financial Officer, principal financial officer and principal accounting officer, effective September 9, 2026.

1 verified record · 1 company · current seat on the record: TransCode Therapeutics, Inc.

Career line from the records

1

Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.

  1. 2026-09-11InterimTransCode Therapeutics, Inc.current seat

    TransCode Therapeutics, Inc. names John Tattory interim CFO

    Named as the incoming officer, Interim Chief Financial Officer, principal financial officer and principal accounting officer

    effective September 9, 2026 · 8-K filed September 11, 2026 · sec.gov, Item 5.02

Companies

1

Transcode Therapeutics, Inc.RNAZ

Pharmaceutical Preparations

This page lists only verified filing records that name John Tattory, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.